Tivic Health Systems, Inc.
TIVC
$3.50
-$0.18-4.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -33.67% | -22.00% | -21.73% | -36.61% | -36.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -33.67% | -22.00% | -21.73% | -36.61% | -36.12% |
| Cost of Revenue | -12.49% | -21.18% | -29.68% | -45.12% | -42.27% |
| Gross Profit | -99.30% | -24.31% | 10.71% | -0.87% | -4.65% |
| SG&A Expenses | -36.75% | -23.12% | -24.09% | -23.15% | -20.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.63% | -22.83% | -25.70% | -25.67% | -21.10% |
| Operating Income | 31.34% | 22.95% | 26.32% | 23.70% | 18.36% |
| Income Before Tax | 31.40% | 22.22% | 25.65% | 23.70% | 18.34% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 31.40% | 22.22% | 25.65% | 23.70% | 18.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.40% | 22.22% | 25.65% | 23.70% | 18.34% |
| EBIT | 31.34% | 22.95% | 26.32% | 23.70% | 18.36% |
| EBITDA | 31.31% | 22.93% | 26.27% | 23.70% | 18.36% |
| EPS Basic | 91.56% | 83.93% | 75.52% | -6.23% | -- |
| Normalized Basic EPS | 91.53% | 83.93% | 75.52% | -6.23% | -- |
| EPS Diluted | 91.56% | 83.93% | 75.52% | -6.23% | -- |
| Normalized Diluted EPS | 91.53% | 83.93% | 75.52% | -6.23% | -- |
| Average Basic Shares Outstanding | 517.20% | 678.55% | 1,534.47% | 2,107.63% | -- |
| Average Diluted Shares Outstanding | 517.20% | 678.55% | 1,534.47% | 2,107.63% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |